|
|
Volumn 34, Issue 2, 2016, Pages 129-132
|
|
Fresh from the biotech pipeline - 2015
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALIROCUMAB;
BIOSIMILAR AGENT;
CRIZOTINIB;
EVOLOCUMAB;
FILGRASTIM;
INFLIXIMAB;
INSULIN GLARGINE;
LIXISENATIDE;
MALARIA VACCINE;
ORPHAN DRUG;
PALBOCICLIB;
PATIROMER;
RECOMBINANT ERYTHROPOIETIN;
ROCILETINIB;
SACUBITRIL PLUS VALSARTAN;
SEBELIPASE ALFA;
SODIUM ZIRCONIUM CYCLOSILICATE;
SUGAMMADEX;
TALIMOGENE LAHERPAREPVEC;
TOCILIZUMAB;
VENETOCLAX;
NEW DRUG;
ARTICLE;
BIOTECHNOLOGY;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
PRIORITY JOURNAL;
UNITED STATES;
DRUG INDUSTRY;
LEGISLATION AND JURISPRUDENCE;
ORGANIZATION AND MANAGEMENT;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84957543652
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3472 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
